221 GENES FOUND

? »

Limit search: Premium | Premium (Subcell) | Premium (Cell line)

Page of 5 | next »

Show / hide columns »

XML | RDF | TAB

Gene

 

 

Gene description

x

 

 

Protein class

x

 

 

 

 

Tissue

Subcell

Cell line

Cancer

 

 

 

 

 

 

RNA tissue category

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 

A4GNTAlpha-1,4-N-acetylglucosaminyltransferasePredicted secreted proteins
Tissue enriched
ABCC2ATP-binding cassette, sub-family C (CFTR/MRP), member 2Cancer-related genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Group enriched
ABCG2ATP-binding cassette, sub-family G (WHITE), member 2Cancer-related genes
CD markers
Predicted membrane proteins
Tissue enhanced
ACEAngiotensin I converting enzymeCandidate cardiovascular disease genes
CD markers
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Group enriched
ACE2Angiotensin I converting enzyme 2Enzymes
FDA approved drug targets
Predicted membrane proteins
Tissue enhanced
ACY1Aminoacylase 1Disease related genes
Enzymes
Plasma proteins
Potential drug targets
Group enriched
ACY3Aspartoacylase (aminocyclase) 3Enzymes
Tissue enhanced
ADAAdenosine deaminaseDisease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Tissue enriched
AGR2Anterior gradient 2Predicted secreted proteins
Tissue enhanced
AGR3Anterior gradient 3Predicted secreted proteins
Tissue enhanced
AKR1B10Aldo-keto reductase family 1, member B10 (aldose reductase)
Tissue enhanced
AKR1B15Aldo-keto reductase family 1, member B15
Tissue enhanced
ALDH3A1Aldehyde dehydrogenase 3 family, member A1Enzymes
Tissue enhanced
ALDOBAldolase B, fructose-bisphosphateCancer-related genes
Disease related genes
Enzymes
Plasma proteins
Potential drug targets
Group enriched
ANPEPAlanyl (membrane) aminopeptidaseCD markers
Enzymes
Plasma proteins
Predicted membrane proteins
Group enriched
ANXA10Annexin A10
Tissue enriched
ANXA13Annexin A13Plasma proteins
Tissue enhanced
AOC1Amine oxidase, copper containing 1Enzymes
Predicted secreted proteins
Group enriched
APOA1Apolipoprotein A-ICancer-related genes
Candidate cardiovascular disease genes
Disease related genes
Plasma proteins
Predicted secreted proteins
Group enriched
APOA4Apolipoprotein A-IVCandidate cardiovascular disease genes
Plasma proteins
Predicted secreted proteins
Group enriched
APOBApolipoprotein BCandidate cardiovascular disease genes
Disease related genes
Plasma proteins
Predicted secreted proteins
Group enriched
ARHGDIGRho GDP dissociation inhibitor (GDI) gamma
Tissue enhanced
ATP4BATPase, H+/K+ exchanging, beta polypeptidePredicted membrane proteins
Transporters
Tissue enriched
B3GALT5UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5Predicted secreted proteins
Tissue enhanced
B3GNT3UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3Enzymes
Predicted secreted proteins
Tissue enhanced
B3GNT7UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7Predicted secreted proteins
Tissue enhanced
B4GALNT2Beta-1,4-N-acetyl-galactosaminyl transferase 2Predicted membrane proteins
Tissue enhanced
B4GALNT3Beta-1,4-N-acetyl-galactosaminyl transferase 3Enzymes
Predicted secreted proteins
Tissue enhanced
BCAS1Breast carcinoma amplified sequence 1
Tissue enhanced
BEST4Bestrophin 4Predicted membrane proteins
Group enriched
BPIFB1BPI fold containing family B, member 1Plasma proteins
Predicted secreted proteins
Tissue enhanced
BTNL8Butyrophilin-like 8Predicted membrane proteins
Group enriched
C10orf99Chromosome 10 open reading frame 99Predicted secreted proteins
Group enriched
C15orf48Chromosome 15 open reading frame 48
Tissue enhanced
C17orf78Chromosome 17 open reading frame 78Predicted membrane proteins
Group enriched
C1orf106Chromosome 1 open reading frame 106
Tissue enhanced
CA1Carbonic anhydrase IEnzymes
FDA approved drug targets
Plasma proteins
Group enriched
CA2Carbonic anhydrase IIDisease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Tissue enhanced
CA4Carbonic anhydrase IVDisease related genes
Enzymes
FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
CA9Carbonic anhydrase IXEnzymes
Predicted membrane proteins
Tissue enhanced
CACNA1ACalcium channel, voltage-dependent, P/Q type, alpha 1A subunitDisease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
CAPN9Calpain 9Enzymes
Tissue enhanced
CDH17Cadherin 17, LI cadherin (liver-intestine)Cancer-related genes
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Group enriched
CDHR2Cadherin-related family member 2Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Group enriched
CDHR5Cadherin-related family member 5Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
CDX1Caudal type homeobox 1Transcription factors
Group enriched
CDX2Caudal type homeobox 2Cancer-related genes
Transcription factors
Group enriched
CEACAM1Carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein)CD markers
Plasma proteins
Predicted membrane proteins
Tissue enhanced
CEACAM5Carcinoembryonic antigen-related cell adhesion molecule 5Cancer-related genes
CD markers
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Group enriched
CEACAM6Carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen)Cancer-related genes
CD markers
Predicted membrane proteins
Group enriched

Page of 5 | next »